Dr. Tim Sayed is Chief Medical Officer of Reactive Medical.  Dr. Sayed is a double board-certified plastic surgeon with nearly two decades of experience who practices in Southern California.  Presently, he owns and operates plastic surgery offices in Southern California and draws patients from all around the United States and world.

Dr. Sayed has served as a medical director and investor at electronic health records and practice management company Modernizing Medicine, with over $300M in financing raised, including Warburg Pincus Series F.  He has also served as vice president and seed investor at Interpreta, which provides precision medicine clinical interpretation solutions.  Dr. Sayed has also served on the board of Fruit Street Health, which has raised over $15M from physician investors and has customer relationships with ShareCare and Walgreens,.  Dr. Sayed also serves on the advisory board of Featherlink, a company which applies artificial intelligence to help improve surgical outcomes.  He also is on the advisory board at Seqster, a software-based platform to manage comprehensive electronic medical records, which has received a strategic funding from Takeda.

Dr. Sayed oversees product development, marketing and brings academic knowledge and clinical experience in aesthetics, anti-aging, skincare, and health technology. Dr. Sayed completed medical training at UCSF and surgical residency at Harvard Medical School.  He holds a B.S. in electrical engineering and computer sciences from Berkeley, M.D. from UCSF School of Medicine, and M.B.A. from the Kellogg School of Management at Northwestern University.